Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
<p>Supplementary Table S2</p>
محفوظ في:
| المؤلف الرئيسي: | Noor Jailkhani (16015810) (author) |
|---|---|
| مؤلفون آخرون: | Karl R. Clauser (16015813) (author), Howard H. Mak (14958336) (author), Steffen Rickelt (14942629) (author), Chenxi Tian (16015816) (author), Charles A. Whittaker (15038249) (author), Kenneth K. Tanabe (16015819) (author), Stephen R. Purdy (16015822) (author), Steven A. Carr (14942649) (author), Richard O. Hynes (14942641) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
حسب: Noor Jailkhani (16015810)
منشور في: (2025) -
Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
حسب: Noor Jailkhani (16015810)
منشور في: (2025) -
Table S1 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
حسب: Tongtong Wu (21903016)
منشور في: (2025) -
Table S2 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
حسب: Tongtong Wu (21903016)
منشور في: (2025) -
Table S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites
حسب: Tongtong Wu (21903016)
منشور في: (2025)